openPR Logo
Press release

COVID-19 is Impacting the Opioids Market to Reach Valuation of $22.3 billion by 2026 | Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Sanofi

05-19-2020 02:53 PM CET | Health & Medicine

Press release from: Allied Market Research

Opioids Market

Opioids Market

Global Opioids Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

The global opioids market is expected to reach $22.3 Billion by 2026, registering a CAGR of 3.2% from 2019 to 2026, in terms of value.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/3556

Opioid drugs are available legally by prescription, such as oxycodone (OxyContin), hydrocodone (Vicodin), codeine, morphine, and others. However, opioids comprise the illicit drug heroin, synthetic opioids including fentanyl, morphine, and other pain relievers.

The opioid market growth is majorly driven by surge in consumption of these drugs to combat pain and rise in geriatric population that are more prone to orthopedic pain. In addition, upsurge in disposable income in developing economies such as India, China, and others contribute to the growth of the market. However, surge in opioid addiction (opioid crisis) across the globe and implementation of stringent government regulation for opioid prescription are the factors anticipated to hamper the market growth. In addition, increase in death rates owing to the overdose of these drugs is a major factor restraining the market growth. For instance, according to the National Institute of Drug Abuse, more than 130 people in the U.S. die daily on overdosing of opioids.

Based on opioid market analysis, the oxycodone segment accounted for 23% of the share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to its increased intake across the globe for pain management. By application, the pain management segment dominated the opioid market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to increase in incidence of migraine, back pain, cancer pain, and others, which in turn fuels the adoption of opioids drugs.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3556

North America accounted for the majority global opioid market share in 2018 and is anticipated to continue this trend during the forecast period. This is attributed to vigorous use and ease of availability of opioid analgesics in this region. However, Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the presence of key players such as Teva Pharmaceuticals, Janssen Pharmaceuticals, Inc., and others in the region. Although opioids are vigorously used for pain management, the market is experiencing slow growth, owing to increase in cases of opioid crisis and deaths due to opioid overdose/misuse.

The Major Key Players Are:

o Purdue Pharma
o Boehringer Ingelheim
o Janssen Pharmaceuticals, Inc.
o Sanofl
o Sun Pharmaceuticals
o Mallinckrodt Pharmaceuticals
o Endo Pharmaceuticals Inc.
o Allergan, Plc
o Pfizer, Inc.

Key Benefits for Opioids Market:

o This report entails a detailed quantitative analysis along with the current opioids market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
o The market forecast is studied from 2018 to 2026.
o The opioids market size and estimations are based on a comprehensive analysis of key developments in the industry.
o A qualitative analysis based on innovative products facilitates strategic business planning.
o The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 is Impacting the Opioids Market to Reach Valuation of $22.3 billion by 2026 | Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Sanofi here

News-ID: 2050960 • Views:

More Releases from Allied Market Research

Gardening Equipment Market Exhibit a Remarkable CAGR of 6.2% and is expected to reach $74.97 billion by 2031
Gardening Equipment Market Exhibit a Remarkable CAGR of 6.2% and is expected to …
Gardening Equipment Market by Product Type (Lawn Mowers, Handheld equipment, Others), by End-User (Residential, Commercial), by Sales Channel (Online, Offline): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global gardening equipment industry generated $40.40 billion in 2021, and is anticipated to generate $74.97 billion by 2031, witnessing a CAGR of 6.2% from 2022 to 2031. Download Sample PDF: https://www.alliedmarketresearch.com/request-sample/A07856 Prime determinants of growth Rapid industrialization & urbanization, surge in middle-class
2030 Forecast | Micro Motor Market Growing at 4.1% CAGR and Expected to reach $56,066.2 million
2030 Forecast | Micro Motor Market Growing at 4.1% CAGR and Expected to reach $5 …
Micro Motor Market by Type (AC and DC), Technology (Brushed Motor and Brushless Motor), Power Consumption (Less Than 10V, 10V-20V, and More Than 20V), and Application (Industrial, Automotive & Aerospace, Healthcare, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global micro motor industry generated $36.47 billion in 2020, and is estimated to generate $56.06 billion by 2030, witnessing a CAGR of 4.1% from 2021
Cross Laminated Timber Market Exhibit a Remarkable CAGR of 8.4% and is expected to reach $3,735.90 million by 2032
Cross Laminated Timber Market Exhibit a Remarkable CAGR of 8.4% and is expected …
The growth of the global cross laminated timber market is driven by growth of the building construction industry, the rise in demand for sustainable construction materials, and various advantages of cross-laminated timber. Cross Laminated Timber Market By Layer Type (3-Ply, 5-Ply, and Other), By Structure Type (Wall, Roof And Floor, and Other), By Application (Residential, and Non-Residential): Global Opportunity Analysis And Industry Forecast, 2023-2032". The cross laminated timber market was valued
Marine Gel Coat Market Size 2024, Industry Share, CAGR, Regional Forecast 2032
Marine Gel Coat Market Size 2024, Industry Share, CAGR, Regional Forecast 2032
According to the report, the global marine gel coat market generated $4.2 billion in 2022, and is anticipated to generate $7.5 billion by 2032, rising at a CAGR of 6.1% from 2023 to 2032. Allied Market Research has recently published a report, titled, "Marine Gel Coat Market Size, Share, Competitive Landscape and Trend Analysis Report by Gelcoat Type, by Resin Type: Global Opportunity Analysis and Industry Forecast, 2023-2032."

All 5 Releases


More Releases for Opioid

MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal
Analgesics Market Driven by Growing Opioid and Non-Opioid Medicine Sales
The application of opioids for the treatment of pain due to cancer, surgery, injury and trauma makes it a bright prospect in the augmentation of analgesics market. Along with opioid drugs, non-opioid is expected to underpin the analgesics market. Prominent companies are grappling to invest in research and development to augment non-opioid drugs through the application of innovative drug delivery approaches which will help in alleviating pain for considerably longer
Opioid Induced Constipation Treatment Market: Mu-opioid Receptor Antagonists to …
Takeda Pharmaceuticals Company, Ltd., with its approved drug Amitiza, holds a majority share in the global market for opioid induced constipation treatment. In 2014 the top three players - Takeda, Valeant Pharmaceuticals International, Ltd., and Boehringer Ingelheim – operated on a collective share of 91.8% of the global market. This is a highly consolidated market but with a large scope for the prominent players to penetrate regions other than North
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in